FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2964609570> ?p ?o ?g. }

• W2964609570 endingPage "2087" @default.
• W2964609570 startingPage "2079" @default.
• W2964609570 abstract "Objectives: To compare the efficacy of emicizumab prophylaxis with that of factor VIII (FVIII) prophylaxis in patients with hemophilia A without inhibitors using two approaches: network meta-analyses (NMA) and additional sub-group analyses from the HAVEN 3 trial.Methods: The NMA used data from trials identified using a systematic literature review and compared bleed rates in patients receiving emicizumab prophylaxis and patients receiving FVIII prophylaxis using a Bayesian, random effects generalized linear model with log link Poisson likelihood. Additional sub-groups of the HAVEN 3 trial included here were defined as patients whose dose-taking behavior met either European label or World Federation of Hemophilia guidelines. A negative binomial regression model was used to conduct an intra-patient comparison of bleed rates within the sub-groups, during treatment with FVIII prophylaxis before entering HAVEN 3 and treatment with emicizumab prophylaxis during HAVEN 3.Results: Four studies were included in the base-case NMA. Evidence showed that the total treated bleed rate was lower with emicizumab prophylaxis compared with FVIII prophylaxis (rate ratio [RR] = 0.36 [95% credible interval (CrI) = 0.13–0.95]). Similar associations were observed in sensitivity analyses. The additional HAVEN 3 analyses also showed lower rates of treated bleeds with emicizumab prophylaxis than with FVIII prophylaxis (RRs [95% confidence interval (CI)] = 0.380 [0.186–0.790] and 0.472 [0.258–0.866] in two sub-groups). These results confirm the original HAVEN 3 intra-patient comparison findings.Conclusions: Combined findings from NMA and additional sub-group analyses of HAVEN 3 support the superiority of emicizumab prophylaxis over FVIII prophylaxis in patients with hemophilia A without inhibitors." @default.
• W2964609570 created "2019-08-13" @default.
• W2964609570 creator A5003583840 @default.
• W2964609570 creator A5015180940 @default.
• W2964609570 creator A5020690225 @default.
• W2964609570 creator A5024068021 @default.
• W2964609570 creator A5025316096 @default.
• W2964609570 creator A5027634414 @default.
• W2964609570 creator A5031572193 @default.
• W2964609570 creator A5058554538 @default.
• W2964609570 creator A5064581168 @default.
• W2964609570 creator A5079086560 @default.
• W2964609570 creator A5083597997 @default.
• W2964609570 creator A5085589474 @default.
• W2964609570 creator A5086435750 @default.
• W2964609570 date "2019-08-13" @default.
• W2964609570 modified "2023-10-01" @default.
• W2964609570 title "Efficacy of emicizumab prophylaxis versus factor VIII prophylaxis for treatment of hemophilia A without inhibitors: network meta-analysis and sub-group analyses of the intra-patient comparison of the HAVEN 3 trial" @default.
• W2964609570 cites W1506421308 @default.
• W2964609570 cites W1566919421 @default.
• W2964609570 cites W1754890660 @default.
• W2964609570 cites W1974965024 @default.
• W2964609570 cites W2010699829 @default.
• W2964609570 cites W2013607072 @default.
• W2964609570 cites W2024737544 @default.
• W2964609570 cites W2040557955 @default.
• W2964609570 cites W2041256954 @default.
• W2964609570 cites W2080205609 @default.
• W2964609570 cites W2095331703 @default.
• W2964609570 cites W2096883889 @default.
• W2964609570 cites W2102368961 @default.
• W2964609570 cites W2105669432 @default.
• W2964609570 cites W2108116635 @default.
• W2964609570 cites W2125435699 @default.
• W2964609570 cites W2125776201 @default.
• W2964609570 cites W2126930838 @default.
• W2964609570 cites W2129821518 @default.
• W2964609570 cites W2133531206 @default.
• W2964609570 cites W2138704278 @default.
• W2964609570 cites W2141377159 @default.
• W2964609570 cites W2148534890 @default.
• W2964609570 cites W2161840983 @default.
• W2964609570 cites W2527038934 @default.
• W2964609570 cites W2747199873 @default.
• W2964609570 cites W2888898681 @default.
• W2964609570 cites W2911739559 @default.
• W2964609570 doi "https://doi.org/10.1080/03007995.2019.1649378" @default.
• W2964609570 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31355677" @default.
• W2964609570 hasPublicationYear "2019" @default.
• W2964609570 type Work @default.
• W2964609570 sameAs 2964609570 @default.
• W2964609570 citedByCount "20" @default.
• W2964609570 countsByYear W29646095702019 @default.
• W2964609570 countsByYear W29646095702020 @default.
• W2964609570 countsByYear W29646095702021 @default.
• W2964609570 countsByYear W29646095702022 @default.
• W2964609570 countsByYear W29646095702023 @default.
• W2964609570 crossrefType "journal-article" @default.
• W2964609570 hasAuthorship W2964609570A5003583840 @default.
• W2964609570 hasAuthorship W2964609570A5015180940 @default.
• W2964609570 hasAuthorship W2964609570A5020690225 @default.
• W2964609570 hasAuthorship W2964609570A5024068021 @default.
• W2964609570 hasAuthorship W2964609570A5025316096 @default.
• W2964609570 hasAuthorship W2964609570A5027634414 @default.
• W2964609570 hasAuthorship W2964609570A5031572193 @default.
• W2964609570 hasAuthorship W2964609570A5058554538 @default.
• W2964609570 hasAuthorship W2964609570A5064581168 @default.
• W2964609570 hasAuthorship W2964609570A5079086560 @default.
• W2964609570 hasAuthorship W2964609570A5083597997 @default.
• W2964609570 hasAuthorship W2964609570A5085589474 @default.
• W2964609570 hasAuthorship W2964609570A5086435750 @default.
• W2964609570 hasBestOaLocation W29646095701 @default.
• W2964609570 hasConcept C126322002 @default.
• W2964609570 hasConcept C141071460 @default.
• W2964609570 hasConcept C167704817 @default.
• W2964609570 hasConcept C168563851 @default.
• W2964609570 hasConcept C187212893 @default.
• W2964609570 hasConcept C2776259030 @default.
• W2964609570 hasConcept C2908647359 @default.
• W2964609570 hasConcept C44249647 @default.
• W2964609570 hasConcept C535046627 @default.
• W2964609570 hasConcept C71924100 @default.
• W2964609570 hasConcept C73269764 @default.
• W2964609570 hasConcept C82789193 @default.
• W2964609570 hasConcept C95190672 @default.
• W2964609570 hasConcept C99454951 @default.
• W2964609570 hasConceptScore W2964609570C126322002 @default.
• W2964609570 hasConceptScore W2964609570C141071460 @default.
• W2964609570 hasConceptScore W2964609570C167704817 @default.
• W2964609570 hasConceptScore W2964609570C168563851 @default.
• W2964609570 hasConceptScore W2964609570C187212893 @default.
• W2964609570 hasConceptScore W2964609570C2776259030 @default.
• W2964609570 hasConceptScore W2964609570C2908647359 @default.
• W2964609570 hasConceptScore W2964609570C44249647 @default.
• W2964609570 hasConceptScore W2964609570C535046627 @default.
• W2964609570 hasConceptScore W2964609570C71924100 @default.
• W2964609570 hasConceptScore W2964609570C73269764 @default.
• W2964609570 hasConceptScore W2964609570C82789193 @default.

• next